
Gangliosidosis-1 (GM-1) disease is caused by the absence or significantly reduced level of a vital
enzyme called beta-galactosidase (GLB1). Without GLB1, a fatty substance or lipid called GM-1
ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation, also called “
substrate,” causes progressive damage to the cells.
The Juvenile and Late Onset forms of GM-1 occur when the mutations allow the GLB1 enzyme to function a little bit. Just a small increase in GLB1 activity is enough to delay the onset and slow the progression of symptoms.
GM-1 is an
autosomal recessive genetic disorder. Both parents must be a carrier for children to be at risk. There is a 25% chance with each pregnancy the child will be affected.
GM-1 ‘breeds true’ in a family. If one child is diagnosed with infantile GM-1 the other children are only at risk for the infantile form. One set of parents could not have children with both the infantile and juvenile forms of the disease.
The
gene that causes GM-1 is located on
chromosome 3, specifically 3p21.33.

Genetic Allicance
www.geneticalliance.org
Rare Diseases
www.rarediseases.org
Neurological Disorders
www.ninds.nih.gov
Biotechnology Info
www.ncbi.nlm.nih.gov
National Tay-Sachs & Allied Diseases Association
2001 Beacon Street
Suite 204
Boston, MA 02135
info@ntsad.org
800-906-8723 phone
617-277-0134 fax
The Organization
Home
About NTSAD
Mission & Vision
Board of Directors
Staff & Profiles
Chapters & Affiliates
Scientific Advisory Committee
Financials
Our History
News
Library Documents
Glossary
Contact
Search
Member Login
The Diseases
Tay SachsFind Support
Annual Family ConferenceResearch
Potential Therapies